Modality's Neurological Lab Test makes clinical trials faster, reduces failures, and increases the ROI of drugs. It uses multimodal AI to produce accurate metrics of facial and speech behaviors, that are predictive of the target disease.
The Neurological Lab Test is in production. It is being used at multiple renowned institutions in IRB-approved clinical trials and drug trials, e.g. at: * UCSF, San Francisco, CA * UT Dallas, Dallas, TX * UT Austin, Austin, TX * Retrotope, Inc., Los Altos, CA There are many more institution various stages of preparation (IRB approval pending, LOIs, pilots), e.g. * Massachusetts General Hospital, Boston, MA * Verge Genomics, South San Francisco, CA * AcuraStem, Monrovia, CA * LEO Pharma, Copenhagen, DK * Purdue University, West Lafayette, IN